Can you trip your way to a younger biological age? 🍄


Hi Reader,

Happy almost-Thanksgiving 🦃!

Before you sit down to feast, I want to talk about something usually reserved for “trips” rather than treatment plans: Magic Mushrooms.

For years, we’ve looked at psilocybin as a tool for the mind. But news dropping this week suggests it might be a tool for the body—specifically, for slowing down biological aging.

Plus: The FDA just approved a massive breakthrough in genetic medicine for heart health, and a new study from the Salk Institute just flipped our understanding of epigenetics on its head.

Let's dive in.

Can You "Trip" Your Way to a Younger Biological Age?

We're witnessing a pivot in psychedelic medicine.

Until now, the narrative has been psychiatric: using psilocybin to treat depression, PTSD, and addiction. The benefit was assumed to come from the experience—the trip itself rewiring mental patterns.

But on Monday, Psyence Biomedical announced the launch of a first-of-its-kind clinical trial. They aren't looking at mood. They're looking at biological aging.

The science that started it all

This is the first corporate trial investigating psilocybin's effects on biomarkers of aging rather than mental health endpoints.

Why make this leap? Preclinical data has been quietly building a case:

  • Psilocin (the active metabolite) extended survival in aged mice
  • Human cells lived up to 50% longer in vitro when exposed to it
  • The mechanism appears to involve stress response modulation, mitochondrial function, and possibly telomere preservation

The implication: the benefit might be cellular—improving mitochondrial function and reducing oxidative stress regardless of the psychological experience.

What this means for longevity

If this trial shows movement in biological age clocks or inflammatory markers, psilocybin graduates from "therapy session drug" to potential "longevity therapeutic."

It also reframes the mechanism entirely. We thought you needed the trip. Maybe you just need the molecule.

What should you actually do with this information?

Right now: Probably Nothing.

This is a Phase 1/2 trial. And while I'm a *big* optimist here (my prior company was in the psychedelics world!), we don't have human longevity data yet. Anyone selling you psilocybin as an anti-aging intervention today is ahead of the science.

Questions to ask if someone pitches you psilocybin for longevity:

  • What biomarkers are you measuring? (If they can't answer specifically, walk away)
  • What's the dosing protocol, and is it based on the psychiatric literature or actual aging research?
  • Are you monitoring for cardiac effects? (Psilocybin affects 5-HT2B receptors, which matter for heart valve health with repeated dosing)

What I'm watching for:

  • Does it move epigenetic clocks?
  • Does it reduce inflammatory markers independent of mood changes?
  • What's the safety profile with repeated low-dose exposure over months/years?

In 5 years, will microdosing be considered a mental health hack—or a standard part of a cellular renewal protocol? This trial will start to answer that question.

Subscribe or share our newsletter for longevity updates

The inflammation you've been told is inevitable... isn't

Now let's talk about something you can actually act on this week.

"Inflammaging" is the chronic, low-grade inflammation that accumulates as we age. Not the acute inflammation from a sprained ankle—a slow, systemic smolder. Elevated CRP. Pro-inflammatory cytokines ticking up year after year.

Why should you care? This background inflammation is linked to nearly every age-related disease: heart disease, Alzheimer's, cancer, frailty. Many researchers consider it the central driver of biological aging.

For years, the assumption was that this inflammatory creep was simply inevitable. Part of getting old.

A study published in Nature Aging says otherwise.

The study that broke the model

Researchers compared inflammatory markers across four populations: two industrialized (Italy and Singapore) and two non-industrialized (the Tsimane in Bolivia and the Orang Asli in Malaysia).

The Tsimane and Orang Asli don't develop inflammaging. Their inflammatory profiles stay flat throughout their entire adult lives. No age-related rise in CRP. No chronic smoldering.

Here's what makes this wild: these populations have massive pathogen exposure. Roughly 66% of Tsimane and 70% of Orang Asli harbor parasitic infections. By conventional thinking, they should be MORE inflamed, not less.

But they're not.

What this actually means

The researchers conclude that inflammaging isn't intrinsic to human aging—it's a mismatch disease.

Our immune systems evolved for constant pathogen defense, daily physical activity, and whole foods. Instead, we've given them sedentary lifestyles, ultra-processed diets, and disrupted circadian rhythms.

The chronic inflammation we've been told is "normal aging"? It's our biology screaming that something is wrong with our environment.

What you can actually do about it

If inflammation isn't hardwired, it's addressable. Here's the "ancestral alignment" framework I keep coming back to:

Movement – The Tsimane walk 15,000+ steps daily. You don't need to match that, but daily movement isn't optional. It's anti-inflammatory medicine.

Whole foods – Not a specific diet. Just: things that were recently alive, minimally processed. The less it looks like what your great-grandmother ate, the more inflammatory it probably is.

Circadian alignment – Light exposure in the morning, darkness at night. Your immune system runs on a clock. Disrupting it drives inflammation.

Social connection – Loneliness is inflammatory. Literally. The Tsimane live in tight-knit communities. This Thanksgiving, the time with family might be doing more for your longevity than any supplement.

Pathogen exposure (controversial) – Some researchers think our lack of immune challenges contributes to inflammaging. I'm not saying go get parasites. But maybe don't Purell everything, let your kids play in the dirt, and stop fearing every microbe.

For Thanksgiving specifically

I'm not saying skip the pie. One meal doesn't drive inflammaging—chronic daily mismatches do.

The Tsimane aren't doing keto. They're not intermittent fasting. They're not taking supplements. They're living in metabolic congruence with their environment.

Enjoy the feast. Then go for a walk with your family afterward instead of collapsing on the couch. That's ancestral alignment in action.

Subscribe or share our newsletter for longevity updates

⚡ Longevity Science Quick Hits!

💉 FDA Approves First RNAi Drug for Lipid Control

Plozasiran (brand name REDEMPLO) got FDA approval on November 18th. This small interfering RNA silences the APOC3 gene in your liver—removing the "brake" on triglyceride clearance.

80% reduction in triglycerides. 83% reduction in pancreatitis risk. One injection every few months. This validates RNAi as a platform for metabolic aging—precision genetic medicine, not broad-spectrum drugs. If broader trials succeed, it could become the "statin of triglycerides" for millions.

🧬 Your DNA Writes Its Own Epigenetic Code

A Salk Institute study in Nature Cell Biology just flipped our understanding of epigenetics.

The old model: DNA is hardware, epigenetics is software that degrades randomly with age. The new finding: specific genetic sequences actually instruct where methylation marks get placed. Your hardware writes its own software. Why it matters: instead of trying to broadly "fix" methylation (messy), we might be able to edit specific DNA sequences that force the body to repair its own epigenetic aging. Targeted engineering, not shotgun approaches.

🏦 Manulife Commits $350M to Longevity

The insurance giant launched a Global Longevity Institute backed by $350 million.

Why this matters more than another VC raise: Insurers are in the business of modeling risk. When they invest at this scale, it's because they've calculated that extending healthspan is cheaper than paying for decades of chronic disease. Longevity isn't a wellness trend anymore—it's actuarial math.

💪 Muscle-Sparing Weight Loss Gets $7.2M

MitoRx Therapeutics raised £5.5M ($7.2M) for Myo-004, a mitochondrial therapeutic designed to drive fat loss while preserving lean muscle.

Their approach targets mitochondrial efficiency rather than appetite—fat oxidation up, muscle wasting down. This addresses the exact sarcopenia concern many doctors worry about.

Where You Can Find Me

👂 Molecular You Webinar – Dec 3, Virtual. This is geared toward clinicians interested in what's coming around the corner in concierge medicine!

🚀 The Longevity Global Summit 2025 – Dec 9-10, Novato, CA. Clinical Panel. I’m so excited to speak at the Buck Institute with the movers and shakers of longevity! Code SUMMITSPEAKER15 for 15% off

🎉 A4M Longevity Fest – Dec 12-14, Las Vegas, NV. This is oriented toward practitioners in longevity, with more clinical talks and exhibits. Betting we'll learn a ton here!

👱🏻‍♀️👩🏻‍🦰👩🏻👧🏽👧🏾 Livelong Women’s Health Summit – April 17-18, 2026, SF, CA. Delighted to join 50 other thought leaders in speaking on women's longevity! Also, Black Friday deal.

Support The Longevity Letter via your longevity purchases

NeuroAgeTx is offering the most comprehensive and science-backed brain aging package to The Longevity Letter readers at up to 61% off (affiliate link here)

Timeline offers the patented Urolithin A for scientifically proven mitochondrial support. Their MitoImmune trial just published showing reversal of immune cell exhaustion in 28 days. (Code CARECORE for 10% off).

What I'm thinking about this week

The longevity field is splitting into two tracks:

Track 1: Futuristic interventions we can't act on yet (psilocybin trials, mRNA plaque reversal, genetic editing)

Track 2: Ancestral basics we keep rediscovering (movement, whole foods, sleep, connection)

The irony? Track 2 has better evidence right now. The Tsimane aren't waiting for clinical trials. They're just living in a way that doesn't fight their biology.

This Thanksgiving, I'm grateful for both tracks. The science pushing boundaries gives me hope. The basics give me something to do today.

Enjoy your feast. Take a walk afterward. Hug your family. Those moments of connection might be doing more for your longevity than anything in this newsletter.

See you next week,

Hillary Lin, MD

Co-Founder & CEO

Care Core

Follow me for more longevity insights: YouTube | LinkedIn | Instagram | TikTok

Want to turn your wellness brand into a full-service health destination? Learn about Care Core's platform or Get Started Here

113 Cherry St #92768, Seattle, WA 98104-2205
Unsubscribe · Preferences

Hillary Lin, MD

💪 Stanford MD, Internal Medicine Board Certified Physician 💪 Longevity, Healthspan, Proactive Health 💪 Serial founder, Newsletter, Podcast https://hillarylinmd.com

Read more from Hillary Lin, MD

Hi Reader, Are you at Longevity Global Summit or A4M next week? Let me know! I've been tracking my food this month — something I do quarterly to recalibrate after things get a bit wild with travel and the holidays. At Thanksgiving, Gemini AI nailed it. Protein, carbs, fat — broken down by each item on the plate, with reasonable estimates for portion sizes. No manual logging. No scanning barcodes. And as you'll see in this issue, that same leap in innovation is happening in longevity science,...

Hi Reader, Where is longevity headed? We've been hearing about 100+ biomarkers, peptides, and hormones—but is that what's really around the corner? I just got back from three days at Eudemonia in Palm Beach, and I have thoughts. Today I'll share the topic I'm most excited about in longevity right now, plus the one I'd tell you not to spend money on yet. Hang on - this is a big newsletter issue (and totally worth it!). At Eudemonia, I had the chance to catch up with dozens of friends - movers...

Is Melatonin Increasing Heart Failure Risk?

Hi Reader, Your inbox is probably full of alarming headlines about melatonin this week. Let's cut through the noise. If you've seen the news about melatonin potentially increasing heart failure risk by 90%, you're likely wondering: Should I toss that bottle in my medicine cabinet? Was my doctor wrong to suggest it? And why does everyone online seem to have a different opinion? Let's dig into what we actually know—and what you can do with that information. There was quite a lot of drama in the...